Apimeds Pharmaceuticals US, Inc. (APUS)
ASE · Healthcare · Drug Manufacturers - Specialty & Generic
$1.28
+2.40%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$19.3M
Shares Outstanding
15.1M
Exchange
ASE
Currency
USD
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.7M | -1.8M | -7.0M | -12.2M |
| Net Income | -2.7M | -1.8M | -1.2M | -35.1M |
| Diluted EPS | $-0.26 | $-0.14 | $nan | $-2.26 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -640K | -747K | -1.3M | -11.9M |
| Net Income | -669K | -778K | -1.4M | -6.0M |
| Diluted EPS | $-0.06 | $-0.07 | $-0.12 | $-0.55 |